Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Amanda, Versteilen"'
Autor:
Arjen Companjen, Joanne Goodman, Amanda Versteilen, Marianne Scheel Fjording, Ulrich Kunz, Philip Timmerman, Susanne Pihl, Karen Elsby, Timo Piironen, Ulf Loevgren, Paul Robinson
Publikováno v:
Bioanalysis. 9:1493-1508
The analysis of biomarkers by ligand-binding assays offers significant challenges compared with the bioanalysis of small and large molecule drugs. The presence of endogenous analyte is a commonly cited issue. Also the sourcing and application of appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f86cb0017428ba4bf000bb5da46f1760
https://doi.org/10.4155/bio-2017-0141
https://doi.org/10.4155/bio-2017-0141
Publikováno v:
Human Vaccines & Immunotherapeutics. 10:2089-2097
As India is transitioning from high to intermediate hepatitis A endemicity, the need for hepatitis A vaccination programs increases. This study investigated the immunogenicity and safety of a virosomal hepatitis A vaccine (HAVpur Junior) compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::337eb3506aa3453479b824d2e254a153
https://doi.org/10.4161/hv.28631
https://doi.org/10.4161/hv.28631
Autor:
Begona Barroso, Christian Herling, Stephanie Fischmann, Neil Henderson, Philip Timmerman, Karen Elsby, Clare Kingsley, Susanne Pihl, Birgit Jaitner, Ulrich Kunz, Amanda Versteilen, Stewart Bates, Daniela Stoellner, Arjen Companjen
Publikováno v:
Bioanalysis. 4:1883-1894
Biomarkers have become increasingly important in drug development and many bioanalysts are getting involved. Consequently, different views on how to approach the bioanalysis of biomarkers have been published or are being developed. The European Bioan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5ca1fa6281b41dc4beae5de7ddff0ca
https://doi.org/10.4155/bio.12.164
https://doi.org/10.4155/bio.12.164
Publikováno v:
Human vaccinesimmunotherapeutics. 10(7)
As India is transitioning from high to intermediate hepatitis A endemicity, the need for hepatitis A vaccination programs increases. This study investigated the immunogenicity and safety of a virosomal hepatitis A vaccine (HAVpur Junior) compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce26b894e5e4e86767172924ffdce664
https://pubmed.ncbi.nlm.nih.gov/25424821
https://pubmed.ncbi.nlm.nih.gov/25424821
Autor:
Bregje Mommaas, Amanda Versteilen, Mariëlle Verhoeven, Coby Stals, Stefan Kostense, Jenny Hendriks, Mariska ter Haak, Felicia Tirion, Martijn Trommel, Marije Bosch, Wolf Ribbens
Publikováno v:
Bioanalysis. 6(10)
Background: As most vaccines exert their protective capacity by eliciting pathogen-specific antibodies, antibody assays assessing immunogenicity of vaccines in development should be well characterized. Part of the validation of immunogenicity assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d7a7cc33fe34fc262c33f8296a3c70
https://pubmed.ncbi.nlm.nih.gov/24958122
https://pubmed.ncbi.nlm.nih.gov/24958122
Autor:
Nazha Hamdani, Monique de Waard, Andrew Messer, Nicky Boontje, Viola Kooij, Sabine van Dijk, Amanda Versteilen, Regis Lamberts, Daphne Merkus, Cris dos Remedios, Dirk Duncker, Zoltan Papp, Walter Paulus, Ger Stienen, Steven Marston, Jolanda van der Velden
Publikováno v:
Journal of Muscle Research & Cell Motility; Dec2008, Vol. 29 Issue 6-8, p189-201, 13p
Autor:
Martina Rauscher, Maria Rosario Capeding, Amanda Versteilen, Edison Alberto, Partha Bagchi, Patricia Ibarra de Palacios
Publikováno v:
International Journal of Infectious Diseases. :71-78
Summary Objective To evaluate non-inferiority of three doses of Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus Quinvaxem in a single-dose vial administered with conventional syringe in terms of seroconversion/seroprotec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65287b0301c1b15c44d273fef8afde32